TNFRSF1B and cancer: Table 1 shows several studies on the implication of TNFR2 in cancer development and suppressive immune responses. It is worth mentioning that, although several anti-cancer immunotherapeutics have been approved by the Food and Drug Administration (FDA) [12], to date there is no drug approved by the FDA as an TNFR2-antagonist.